Confluent, Inc.CFLTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank17
3Y CAGR-51.2%
5Y CAGR-38.2%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-51.2%/yr
Annual compound
5Y CAGR
-38.2%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
20257.32%
202420.78%
202332.08%
202263.06%
202153.63%
202081.44%
20190.00%